NISCI - Nogo Inhibition in Spinal Cord Injury (NISCI)
Antibodies Against Nogo-A to Enhance Plasticity, Regeneration and Functional Recovery After Spinal Cord Injury - A Multicenter International Randomized Double Blind Placebo Controlled Phase II Clinical Proof of Concept Trial
Sponsor: EMSCI.org
Listed as NCT03935321, this PHASE2 trial focuses on Spinal Cord Injury, Acute and remains completed. Sponsored by EMSCI.org, it has been updated 16 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
16 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Nov 2023 — Jul 2024 [monthly]
Completed PHASE2
-
May 2023 — Nov 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
▶ Show 11 earlier versions
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Sep 2022 [monthly]
Recruiting PHASE2
-
May 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2020 — Apr 2020 [monthly]
Recruiting PHASE2
-
Dec 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Aug 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE2
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EMSCI.org
- Foundation Wings For Life
- Heidelberg University Hospital Spinal Cord Injury Center
- Horizon 2020 - European Commission
- KKS Netzwerk
- State Secretariat for Education Research and Innovation, Switzerland
- Swiss Paraplegic Research, Nottwil
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barcelona, Spain , Basel, Switzerland , Bayreuth, Germany , Berlin, Germany , Bochum, Germany , Halle, Germany , Heidelberg, Germany , Hessisch Lichtenau, Germany , Murnau am Staffelsee, Germany , Nottwil, Switzerland and 3 more locations